CADTH | Homepage

CADTH Is Now Canada’s Drug Agency 

Learn more

New Analysis Examines Role of Conditional Approvals on Access to Promising Oncology Therapies

Read more about New Analysis Examines Role of Conditional Approvals on Access to Promising Oncology Therapies

Improving Our Assessments of Drugs With Companion Diagnostic Tests 

Read more about Improving Our Assessments of Drugs With Companion Diagnostic Tests 

New Report on Emerging Approaches to Economic Evaluations of Tumour-Agnostic Drugs

Read more about New Report on Emerging Approaches to Economic Evaluations of Tumour-Agnostic Drugs

Featured Reports

All Reports
All Reports

Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all

We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.

Learn More
National Capital Region's Top Employers 2024 logo

A National Capital Region’s top employer

National Capital Region's Top Employers 2024 logo

We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2024.

Read More

Latest News

All News

Recent Cybersecurity Incident

In mid-March, we identified a cybersecurity incident in which an external party gained access to an application in our IT systems. We discovered the ...

Symposium 2024 Registration Is Now Open

Registration is now open for Symposium 2024, a flagship event in the health technology assessment (HTA) community. Symposium 2024 will be held on ...

New Analysis Examines Role of Conditional Approvals on Access to Promising Oncology Therapies

Health Canada’s Notice of Compliance with conditions (NOC/c) policy has been effective in providing people in Canada with faster access to new ...

Improving Our Assessments of Drugs With Companion Diagnostic Tests 

As part of our ongoing initiative to improve and modernize our reimbursement review program, Canada’s Drug Agency is introducing the first phase of ...

New Report on Emerging Approaches to Economic Evaluations of Tumour-Agnostic Drugs

Canada’s Drug Agency has published a new report on an economic modelling approach used in evaluations of tumour-agnostic drugs that treat cancer. The ...

Our Commitment to Inclusion, Diversity, Equity, and Accessibility

We are pleased to share our official IDEA Statement, recently approved by our Board of Directors and Executive Leadership Team.   This statement ...
All News

Canada’s Drug Agency

Canada’s Drug Agency is a pan-Canadian health organization.

Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. 

Upcoming Events

All Events

HTAi 2024 Annual Meeting

-
8:00 am
Read More HTAi 2024 Annual Meeting

Real-World Evidence Bootcamp

-
8:00 am
Read More Real-World Evidence Bootcamp

An Update on the Development of Newborn Screening Guidance in Canada 

Thursday, July 11, 2024, 1:00 p.m. to 2:00 p.m. ET   
Read More An Update on the Development of Newborn Screening Guidance in Canada 
All Events
postcard

Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.